Veeva Systems Long-term Debt / Capital 2012-2025 | VEEV
Current and historical long-term debt / capital for Veeva Systems (VEEV) from 2012 to 2025. Long-term debt / capital can be defined as a measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Veeva Systems long-term debt / capital for the three months ending January 31, 2025 was 0.00.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $38.020B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.898B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.354B | 118.21 |
| Inspire Medical Systems (INSP) | United States | $4.713B | 91.55 |
| IRhythm Technologies (IRTC) | United States | $3.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.848B | 213.46 |
| Enovis (ENOV) | United States | $1.975B | 12.22 |
| Schrodinger (SDGR) | United States | $1.872B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.737B | 0.00 |
| Phreesia (PHR) | United States | $1.467B | 0.00 |
| Omnicell (OMCL) | United States | $1.464B | 31.58 |
| Azenta (AZTA) | United States | $1.204B | 56.04 |
| 10x Genomics (TXG) | United States | $1.011B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.536B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 307.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Standard BioTools (LAB) | United States | $0.421B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.363B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.277B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.209B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| Pulmonx (LUNG) | United States | $0.194B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.33 |
| 111 (YI) | China | $0.071B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Outset Medical (OM) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |